Long‐term intermittent treatment with low‐dose 5‐aminosalicylic enemas is efficacious for remission maintenance in ulcerative colitis

Abstract

The scheduled oral + topical 5-ASA treatment, at the lowest cumulative topical dosage tested over the longest known observation period, is efficacious in improving clinical outcome and decreasing overall costs in UC patients.